CD8A and neoplasm: In LUAD patients, we attempted to determine whether SLC2As are correlated with the marker genes of different immune cell types, such as CD8+ T cells, monocytes, T cells (general), M1 and M2 macrophages, B cells, neutrophils, tumor-associated macrophages (TAMs), natural killer cells, and DCs.